Cambridge Journals Online

Aygun Ertugrul and Herbert Y. Meltzer (). Antipsychotic drugs in bipolar disorder. The International Journal of Neuropsychopharmacology, 6 , pp 277-284
doi:10.1017/S1461145703003560

Nuria Cruz, Jose Sanchez-Moreno, Ferran Torres, Jose Manuel Goikolea, Marc Valentí and Eduard Vieta Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. The International Journal of Neuropsychopharmacology, Published online by Cambridge University Press 11 Dec 2008 doi:10.1017/S1461145709990344

Robert van Reekum, Diana Clarke, David Conn, Nathan Herrmann, Goran Eryavec, Tammy Cohen and Laurie Ostrander (). A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia. International Psychogeriatrics, 14 , pp 197-210
doi:10.1017/S1041610202008396

Robert C. Durham, Peter L. Fisher, Linda R. Trevling, Cathryn M. Hau, Karen Richard and John B. Stewart (). ONE YEAR FOLLOW-UP OF COGNITIVE THERAPY, ANALYTIC PSYCHOTHERAPY AND ANXIETY MANAGEMENT TRAINING FOR GENERALIZED ANXIETY DISORDER: SYMPTOM CHANGE, MEDICATION USAGE AND ATTITUDES TO TREATMENT. Behavioural and Cognitive Psychotherapy, 27 , pp 19-35


Richard J. Lilford, David A. Braunholtz and Sarah J. L. Edwards (). CLINICAL TRIALS . International Journal of Technology Assessment in Health Care, 16 , pp 1210-1213
doi:10.1017/S0266462300103241

Stephen V. Faraone, Elizabeth J. Short, Joseph Biederman, Robert L. Findling, Christine Roe and Michael J. Manos (). Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug–placebo and drug–drug response curve analysis of a naturalistic study. The International Journal of Neuropsychopharmacology, 5 , pp 121-129
doi:10.1017/S1461145702002845

Wendy A. Kennedy, Claudine Laurier, Jean-Luc Malo, Heberto Ghezzo, Jocelyne L'archevêque and André-Pierre Contandriopoulos (). DOES CLINICAL TRIAL SUBJECT SELECTION RESTRICT THE ABILITY TO GENERALIZE USE AND COST OF HEALTH SERVICES TO “REAL LIFE” SUBJECTS?. International Journal of Technology Assessment in Health Care, 19 , pp 8-16
doi:10.1017/S0266462303000023

Bruno Stankoff, Catherine Lubetzki and Michel Clanet (). Modafinil for the Treatment of Fatigue in Multiple Sclerosis. Progress in Neurotherapeutics and Neuropsychopharmacology, 1 , pp 27-36
doi:10.1017/S1748232105000042

Paul H. Gordon, Joseph Choi, Dan H. Moore and Robert G. Miller (). Early Phase Trials of Minocycline in Amyotrophic Lateral Sclerosis. Progress in Neurotherapeutics and Neuropsychopharmacology, 1 , pp 63-77
doi:10.1017/S1748232105000078